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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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Striving for brave new brains
As I turned 52 on December 31 and a new year dawned on the world, I
came ever closer to onset of Huntington’s disease, the cruel killer that took
my mother’s life in 2006 at the age of just 68.
However, in 2012 I also will live with the hope that, as science and
medicine progress with time, researchers will control and perhaps even
eradicate HD.
Indeed, we stand on the verge of a new age. Neuroscience, brain scans, our
understanding of genetics, and brain-machine interfaces will vastly
improve the health and capabilities of the brain and perhaps enable the
cure of HD, Alzheimer’s, Parkinson’s, Lou Gehrig’s, stroke, and numerous
other maladies of the central nervous system.
On Christmas and my birthday I was able to celebrate the results of my
annual check-up at the local HD clinic on December 20: the doctor
marveled at how, despite carrying the same genetic defect as my mother, I
have yet to show any apparent external symptoms of the disease (click here
and here to read about my HD-avoidance strategies).
With the predicted biotechnological advances, those of us who are genepositive may someday put bionic brains on our birthday wish lists – brains
without risk of HD and that enhance mental capabilities far beyond
anything we can currently imagine. Even sooner, advances in medicine
may deliver drugs and techniques that counteract the cruel changes
wrought in HD brains.
Breathtaking predictions
I contemplated these possibilities during my holiday reading, which
included Judith Horstman’s The Scientific American Brave New Brain:
How Neuroscience, Brain-Machine Interfaces, Psychopharmacology,
Epigenetics, the Internet, and Our Own Minds Are Stimulating and
Enhancing the Future of Mental Power, an exciting, easy-to-read synopsis
of recent advances in brain science.
Horstman outlines how brain scientists predict breathtaking
breakthroughs by mid-century – most with a firm foot in current reality.
According to scientific forecasters, “computer chips or mini-processors in
the brain will expand memory; control symptoms of brain disease, from
Parkinson’s disease to depression and anxiety; and wirelessly receive and
transmit information so that you won’t need a cell phone or a computer to
stay in touch.”
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“Brain surgery will be a thing of the past except in the most severe cases,”
Horstman continues. “Advanced neuroimaging will identify mental illness
and brain disease before symptoms show and in general be used to ‘read’
minds and predict and control behavior. Microscopic robots – nanobots –
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will enter your bloodstream to diagnose and repair brain damage. Protein
molecules will travel your brain in a similar way to turn on or off brain
cells or genes responsible for brain diseases.”
Brave New Brain explores numerous other current and potential facets of
brain health and related technologies, including:
● neurogenesis (the growth of new brain cells);
● deep brain stimulation and “brain pacemakers” (using electricity to
stimulate brain health and performance);
● brain-nurturing mental and physical practices such as meditation,
breathing, and yoga;
● the impact of digital technology on the brain and its integration into the
brain;
● artificial intelligence;
● miniature cameras for broadcasting images of the inner workings of the
brain;
● thought-activated neural implants (for example, for working mechanical
limbs);
● prostheses of portions of the brain (people are already living with
artificial retinas and cochleas, the auditory portion of the inner ear);
● and, in one forecaster’s view, the downloading of our brains onto chips
“so our consciousness can live on forever, perhaps even downloaded into
robots – or into an avatar, an ageless biological clone,” perhaps making us
an endangered species increasingly replaced by cyborgs.
“Neuroethicists” and others worry that “humans will become machines,”
Horstman observes. These individuals also point out new issues involving
privacy in genetic testing; ownership of body parts, tissues, and genes;
insurance discrimination; potential abuse of new technologies by
employers and others; and the impact of all of these changes on social
equality and our way of controlling criminals. Neuroethicists are grappling
with these many issues.
Curing dementia
According to Horstman, Alzheimer’s, other dementias, and perhaps even
mental retardation will be “preventable, curable, and even reversible in
many people.”
The demand for cures is immense: some two billion people worldwide
suffer from a brain-related illness, with an annual economic cost of more
than $2 trillion, Horstman writes. Almost half of all people over age 85
develop dementia, and by 2050 an estimated 100 million individuals will
experience this condition.
Offering a glimpse of how these cures could take place, Horstman writes of
“brain boggling” nanotechnologies such as “preparing specialized protein
molecules that swim to a predetermined site and are activated externally
by probes or lasers that turn off or on specific genes.”
This kind of “nanomedicine” would allow medical treatments to leap
across the formidable blood-brain barrier, which separates the
bloodstream from the fluid that bathes and cushions our brains, Horstman
explains.
Alnylam’s HD gene-silencing trial
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The trends in neuroscience and related fields mean that scientists someday
will likely control HD and perhaps, as Horstman describes, completely
turn off the gene that causes it.
Key research in “gene silencing” already holds great promise.
In partnership with Medtronic, in 2012 Alnylam Pharmaceuticals plans to
apply to the federal Food and Drug Administration (FDA) to conduct a
Phase I clinical trial of a drug containing ALN-HTT, a small interfering
RNA molecule (siRNA) that doctors will inject into the brains of trial
participants.
Conducting a brain operation, doctors will run thin tubing under the skin
from a Medtronic-designed pump to a nodule at the top of the patients’
heads, and from that point a very fine needle will deliver the drug into the
putamen, one of the regions of the brain most devastated by HD (click here
to read more).
If the Phase I trial demonstrates the safety of ALN-HTT, Alynlam will
proceed to Phase II to measure the efficacy of the drug.
Alnylam intends to use ALN-HTT to silence the huntingtin gene so that
less huntingtin protein is produced to harm brain cells. If successful, the
treatment would save brain cells from dying and slow down and possibly
even reverse the course of HD.
A decade ago, this approach seemed like science fiction. Today, it provides
immense hope that HD will be controlled in our lifetimes.
On December 28, 2011, Alnylam presented a highly positive report: testing
of ALN-HTT in non-human primates demonstrated “widespread
distribution of the siRNA and significant silencing of the huntingtin
mRNA.” The drug was well tolerated.
Conducted in collaboration with Medtronic and a research team at the
University of Kentucky, the study will greatly facilitate the FDA application
for a human trial.
Isis Pharmaceuticals, Inc. is developing a similar approach for treating HD
and hopes to apply for its own Phase I clinical trial, perhaps within the
next year or two (click here to read more).
The pioneering HD community
As Horstman describes, such gene silencing techniques only scratch the
surface of the great potential in brain-disease treatments. Indeed, we may
someday look back on these initial attempts as primitive.
But they are revolutionary. We in the HD community are helping to
pioneer this revolution in brain science by participating in research studies
and clinical trials, fighting the terrible stigma associated with the disease,
and, as I did last February, exiting the terrible “HD closet” to tell the world
about the need to defeat HD and other neurological disorders.
HD families no longer stand alone. Our movement has gone global – with
international conferences run by research organizations, numerous HDrelated websites, and the establishment of Enroll-HD, a multi-country
database of HD-affected, gene-positive, and untested at-risk individuals.
Just last month a new HD group formed in China, the world’s most
populous country.
We stand on the frontier of science, and for this reason in 2012 and beyond
we can forge ahead proudly and bravely.
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It’s up to us to lead the way. If we all unite and participate in this great
movement, we can help build toward the bionic brains of the future.

Posted by Gene Veritas at 3:24 PM
Labels: ALN-HTT , Alnylam , anxiety , dementia , depression , discrimination , drug ,
gene , gene silencing , gene-positive , HD closet , Huntington's , meditation ,
memory , neurogenesis , siRNA , stigma

1 comment:
Anonymous said...
Nothing you did contributed to your good fortune on remaining
negligable in symptoms. I came across a number of elderly
persons who were gene positive and had relatives with latish
earlier onsets of HD. It was viewed that they would die of other
causes well before HD made any significant mark on their lives
. Well aside from some of the worries that exist around the
disease.Essentially it's a form of unusual individual luck.
7:31 AM, December 13, 2013
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